MRI Contrast Agents

NEWARK, N.J. — A federal court in New Jersey declined to remand a woman’s claims that FDA-approved contrast agents injected to enhance MRIs caused her Gadolinium Deposition Disease, which darkened her teeth and caused brain fog and memory loss. The court ruled the complaint does not solely rely on state law to allege the FDA colluded with Bayer to conceal safety information about the contract agents from the public.

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Email *

Submit